UCL

UK doctors think Britain’s exit from the European Union will be very bad for the NHS, reveal the results of a study from UCL, the London School of Hygiene & Tropical Medicine (LSHTM) and Queen Mary University of London.

A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.